NexgenRx Inc.
NEGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20 | $18 | $19 | $31 |
| - Cash | $2 | $2 | $17 | $20 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $19 | $17 | $3 | $11 |
| Revenue | $16 | $14 | $12 | $12 |
| % Growth | 19% | 11.1% | 4.9% | – |
| Gross Profit | $13 | $11 | $8 | $8 |
| % Margin | 79.6% | 78.1% | 68.2% | 71.5% |
| EBITDA | $2 | $1 | $2 | $4 |
| % Margin | 14.1% | 7.4% | 13.5% | 36.5% |
| Net Income | $1 | -$0 | -$0 | $4 |
| % Margin | 3.7% | -2.4% | -0.2% | 34.1% |
| EPS Diluted | 0.005 | -0.005 | -0 | 0.054 |
| % Growth | 206.4% | -1,649% | -100.5% | – |
| Operating Cash Flow | $1 | $1 | $3 | $3 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$1 |
| Free Cash Flow | $1 | $1 | $3 | $2 |